AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Eu HIV & Hep Abstracts 2022_56View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022HIV and SARS-CoV-2: the interplay of two wicked problemsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Impacts of Differentiated Service Delivery Model (DSDM) on Adherence (ADH) to clinical appointment Among Children and Adolescent Living with HIV (CALHIV) attending at Mbeya Center of Excellence (COE), Baylor-TanzaniaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Implementation of HCV- infection treatment programm with DAA in armenia among HIV- infected patients in COVID-19 eraView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Switch to ART with BIC/FTC/TAF achieves virological control in patients with low level viremiaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Residual HIV-1 RNA in 4d on/3d off (ANRS 170 QUATUOR) through W96View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Long-term Efficacy, Safety, and Durability of Ibalizumab-based Regimens in Subgroup of TMB- 202 ParticipantsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022K156N integrase substitution in combination with 3’PPT resistance mutations against dolutegravirView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Clonal Case Assessments for Participants Failing with Emergent Integrase Resistance in the DAWNING Second Line StudyView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Detection of mutations associated with antiretroviral drug resistance from HIV proviral DNA in patients with low-level viremiasView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Increasing protease inhibitor resistance mutations among HIV-infected children and adolescents with virologic failureView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Archived HIV-1 drug resistance is driven by NNRTI-mutations and associated with viral replication among adolescents in CameroonView Abstract
